ATE119777T1 - Behandlungsmethoden für osteoporose. - Google Patents

Behandlungsmethoden für osteoporose.

Info

Publication number: ATE119777T1
Authority: AT; Austria
Prior art keywords: osteoporosis; treatment; treatment methods; subject; phosphonate
Prior art date: 1991-02-26

Application number

AT92908494T

Other languages

English (en)

Inventor

Jocelyn Elaine Mcosker

Original Assignee

Procter & Gamble Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-26

Filing date

1992-01-31

Publication date

1995-04-15

1992-01-31 Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma

1995-04-15 Application granted granted Critical

1995-04-15 Publication of ATE119777T1 publication Critical patent/ATE119777T1/de

Links

208000001132 Osteoporosis Diseases 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 abstract 3
229940122361 Bisphosphonate Drugs 0.000 abstract 1
150000004663 bisphosphonates Chemical class 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Removal Of Specific Substances (AREA)

AT92908494T 1991-02-26 1992-01-31 Behandlungsmethoden für osteoporose. ATE119777T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US66177791A	1991-02-26	1991-02-26

Publications (1)

Publication Number	Publication Date
ATE119777T1 true ATE119777T1 (de)	1995-04-15

Family

ID=24655074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92908494T ATE119777T1 (de)	1991-02-26	1992-01-31	Behandlungsmethoden für osteoporose.

Country Status (18)

Country	Link
US (1)	US6329354B1 (de)
EP (1)	EP0573604B1 (de)
JP (1)	JP3727332B2 (de)
KR (1)	KR100240358B1 (de)
AT (1)	ATE119777T1 (de)
AU (1)	AU664368B2 (de)
CA (1)	CA2101275C (de)
CZ (1)	CZ282609B6 (de)
DE (1)	DE69201725T2 (de)
DK (1)	DK0573604T3 (de)
ES (1)	ES2069424T3 (de)
HU (1)	HU215124B (de)
IE (1)	IE65963B1 (de)
NO (1)	NO305581B1 (de)
NZ (1)	NZ241717A (de)
RU (1)	RU2113848C1 (de)
SK (1)	SK90093A3 (de)
WO (1)	WO1992014474A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2119337C1 (ru) *	1992-03-21	1998-09-27	Энтек Гезельшафт фюр Эндокринологише Технологи мбХ	Трансдермальный препарат продленного действия с антиостеопоротической активностью
EP0663919A1 (de) *	1992-10-09	1995-07-26	PHARMACIA & UPJOHN COMPANY	Pyrimidin bisphosphonsäureestern als anti-inflammatorisches mittel
US6399592B1 (en)	1992-12-23	2002-06-04	Merck & Co., Inc.	Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss
AU5953894A (en) *	1992-12-23	1994-07-19	Merck & Co., Inc.	Bisphosphonate/estrogen therapy for treating and preventing bone loss
WO1994026310A1 (de) *	1993-05-15	1994-11-24	Boehringer Mannheim Gmbh	Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
AU701258B2 (en) *	1994-12-28	1999-01-21	Gador S.A.	Bone mass anabolic composition comprising olpadronate
DE19635883A1 (de) *	1996-09-04	1998-03-05	Lohmann Therapie Syst Lts	Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
EP0949928A4 (de) *	1996-11-25	2000-09-13	Merck & Co Inc	Zusammen verabreichte androgene und diphosphonverbindungen zur behandlung von krankheiten
US6376477B2 (en)	1996-11-25	2002-04-23	Merck & Co., Inc.	Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism
US6692763B1 (en) *	1998-11-19	2004-02-17	The Regents Of The University Of California	Methods for treating postmenopausal women using ultra-low doses of estrogen
AR013994A1 (es) *	1998-10-30	2001-01-31	Gador Sa	Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
US6579860B1 (en) *	1998-12-25	2003-06-17	Toray Industries, Inc.	Interleukin-6 production inhibitors
US6326365B1 (en)	1999-07-20	2001-12-04	Apollo Biopharmaceutics, Inc.	Methods of prevention and treatment of ischemic damage
US6339078B1 (en)	1999-07-20	2002-01-15	University Of Florida Research Foundation, Inc.	Methods of prevention and treatment of ischemic damage
US6653298B2 (en)	2000-01-14	2003-11-25	Sterix Limited	Composition
US7335650B2 (en)	2000-01-14	2008-02-26	Sterix Limited	Composition
US20040038946A1 (en) *	2001-04-27	2004-02-26	Wilson Lon J.	Fullerene-based drugs targeted to bone
RU2199273C1 (ru) *	2001-11-05	2003-02-27	Научно-исследовательский институт кардиологии Томского научного центра СО РАМН	Способ оценки кровоснабжения грудины после операций на грудной клетке
WO2009068567A1 (en) *	2007-11-30	2009-06-04	Novartis Ag	C2-c5-alkyl-imidazole-bisphosphonates
DK2459176T3 (en)	2009-07-31	2017-12-04	Gruenenthal Gmbh	Crystallization process and bioavailability
US9169279B2 (en)	2009-07-31	2015-10-27	Thar Pharmaceuticals, Inc.	Crystallization method and bioavailability
US20160016982A1 (en)	2009-07-31	2016-01-21	Thar Pharmaceuticals, Inc.	Crystallization method and bioavailability
US9340565B2 (en)	2010-11-24	2016-05-17	Thar Pharmaceuticals, Inc.	Crystalline forms
US10195218B2 (en)	2016-05-31	2019-02-05	Grunenthal Gmbh	Crystallization method and bioavailability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3553314A (en)	1968-12-23	1971-01-05	Procter & Gamble	Oral compositions for calculus retardation
US3683080A (en)	1970-08-28	1972-08-08	Procter & Gamble	Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
EP0088462A3 (de) *	1982-03-01	1984-06-06	The Procter & Gamble Company	Entzündungshemmende und antirheumatische Zusammensetzung mit Gehalt an einem Organophosphonat und einem Steroiden
DE3583887D1 (de) *	1984-04-30	1991-10-02	Procter & Gamble	Ausruestung fuer die behandlung der osteoporose.
US4761406A (en)	1985-06-06	1988-08-02	The Procter & Gamble Company	Regimen for treating osteoporosis
IL86951A (en)	1987-07-06	1996-07-23	Procter & Gamble Pharma	Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them

1992
- 1992-01-31 AU AU16433/92A patent/AU664368B2/en not_active Ceased
- 1992-01-31 JP JP51158492A patent/JP3727332B2/ja not_active Expired - Lifetime
- 1992-01-31 EP EP92908494A patent/EP0573604B1/de not_active Expired - Lifetime
- 1992-01-31 DK DK92908494.5T patent/DK0573604T3/da active
- 1992-01-31 RU RU93054017A patent/RU2113848C1/ru not_active IP Right Cessation
- 1992-01-31 CZ CS931755A patent/CZ282609B6/cs not_active IP Right Cessation
- 1992-01-31 HU HU9302407A patent/HU215124B/hu not_active IP Right Cessation
- 1992-01-31 AT AT92908494T patent/ATE119777T1/de not_active IP Right Cessation
- 1992-01-31 CA CA002101275A patent/CA2101275C/en not_active Expired - Lifetime
- 1992-01-31 KR KR1019930702547A patent/KR100240358B1/ko not_active Expired - Fee Related
- 1992-01-31 ES ES92908494T patent/ES2069424T3/es not_active Expired - Lifetime
- 1992-01-31 DE DE69201725T patent/DE69201725T2/de not_active Expired - Lifetime
- 1992-01-31 WO PCT/US1992/000854 patent/WO1992014474A1/en not_active Ceased
- 1992-01-31 SK SK900-93A patent/SK90093A3/sk unknown
- 1992-02-25 NZ NZ241717A patent/NZ241717A/en not_active IP Right Cessation
- 1992-02-25 IE IE920584A patent/IE65963B1/en not_active IP Right Cessation
1993
- 1993-01-25 US US08/008,859 patent/US6329354B1/en not_active Expired - Lifetime
- 1993-08-26 NO NO933044A patent/NO305581B1/no unknown

Also Published As

Publication number	Publication date
EP0573604A1 (de)	1993-12-15
CZ282609B6 (cs)	1997-08-13
US6329354B1 (en)	2001-12-11
JP3727332B2 (ja)	2005-12-14
NO305581B1 (no)	1999-06-28
SK90093A3 (en)	1994-09-07
JPH06505501A (ja)	1994-06-23
HU215124B (hu)	1998-09-28
NO933044L (no)	1993-08-26
DE69201725D1 (de)	1995-04-20
ES2069424T3 (es)	1995-05-01
KR100240358B1 (ko)	2000-02-01
HU9302407D0 (en)	1993-11-29
AU1643392A (en)	1992-09-15
NO933044D0 (no)	1993-08-26
IE65963B1 (en)	1995-11-29
AU664368B2 (en)	1995-11-16
CA2101275C (en)	1998-08-04
RU2113848C1 (ru)	1998-06-27
IE920584A1 (en)	1992-08-26
NZ241717A (en)	1997-02-24
CZ175593A3 (en)	1994-04-13
WO1992014474A1 (en)	1992-09-03
DK0573604T3 (da)	1995-05-29
DE69201725T2 (de)	1996-04-18
HUT66429A (en)	1994-11-28
EP0573604B1 (de)	1995-03-15
CA2101275A1 (en)	1992-08-27

Similar Documents

Publication	Publication Date	Title
ATE119777T1 (de)	1995-04-15	Behandlungsmethoden für osteoporose.
RU93054017A (ru)	1997-01-27	Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза
ATE105482T1 (de)	1994-05-15	Behandlung von krebs mit somatostatin und mit analogen davon.
NZ504026A (en)	2002-12-20	Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
PT850068E (pt)	2005-08-31	Extracto lipidico com actividade anti-inflamatoria
ES2133413T3 (es)	1999-09-16	Gel de lecitina inyectable.
ATE218350T1 (de)	2002-06-15	Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
MX9207349A (es)	1993-12-01	Metodos para el tratamiento de osteoporosis utilizando bisfosfonatos y hormona de paratiroides.
ATE152627T1 (de)	1997-05-15	Verfahren zur anregung der immunresponz
ATE161423T1 (de)	1998-01-15	Verwendung von phosphinate zur behandlung der osteoporose
DE3650358D1 (de)	1995-09-07	Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
ATE184788T1 (de)	1999-10-15	Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer
DE69718469D1 (de)	2003-02-20	Verbindungen mit wachtumshormon freisetzenden eigenschaften
ATE157010T1 (de)	1997-09-15	Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ES2089177T3 (es)	1996-10-01	Nuevos peptidos inhibidores.
GR3029319T3 (en)	1999-05-28	Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
ATE249837T1 (de)	2003-10-15	Caspase 8-inhibitoren zur immunsuppression
DE69734349D1 (de)	2006-02-23	Behandlung von knochenleiden mit adrenomedullin
BR9810884A (pt)	2000-09-26	Uso de uma preparação de lipìdeo derivada de uma fonte natural enriquecida
ATE81972T1 (de)	1992-11-15	Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
ATE153859T1 (de)	1997-06-15	Somatotropin zur erhoehung der reproduktiven leistung in rinder
MX9206339A (es)	1993-05-01	Nueva proteina inhibidora de trombina a partir de chinches de monte
UA43389C2 (uk)	2001-12-17	Спосіб зниження рівнів кальцію у сироватці
DE68905479D1 (de)	1993-04-22	Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
MX9605327A (es)	1998-02-28	Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.

Legal Events

Date	Code	Title	Description
1996-01-15	UEP	Publication of translation of european patent specification
2006-10-15	REN	Ceased due to non-payment of the annual fee